Twenty-five developments in medicine safety, treatment access, clinical AI, product quality, public money and the conditions that make care possible — each labelled for what it is: in force, proposed, ordered, audited, under review or announced.
California: dates that changed the legal and access picture — Transaction-review rules now in effect, the narrow scope of the October Medicaid medical-frailty order, and a November 18 provider deadline for a Central Valley maternal-health model.
Quality, manufacturing and public money — FDA potency guidance, two federal audits, China’s device rules in force, India’s batch-release proposal and the organ-procurement final rule.
The conditions that make care possible — A new Ebola snapshot, Canada’s men-and-boys consultation, long-term care in the Americas, care continuity, housing and displacement.
REVIEWED AND APPROVED FOR PUBLICATION · EDITION OF NOVEMBER 3, 2026 · EARLIER EDITIONS BELOW ARE KEPT
October 19, 2026 edition · Record through October 19, 2026, 4:00 PM PT · Supplemental update October 26, 2026 (Ebola, ECDC October 23)
Global signals · October 19, 2026
Ebola (Bundibugyo). DRC: 9,066 confirmed cases and 4,381 deaths across 65 health zones (as of Oct 11). Kenya: 3 confirmed and 1 death, all linked (as of Oct 16). Supplemental update — 26 October 2026, outside the October 19 edition: ECDC (23 Oct) reports Kenya 9 cases including 1 death and Nigeria 1 case; ECDC's EU/EEA risk wording is not a U.S. assessment. Later, ECDC (28 Oct): DRC 10,141 confirmed cases including 4,928 related deaths (cases as of 27 Oct), eight provinces; Kenya 9 cases including 2 deaths (as of 26 Oct).Update, 5 November 2026: WHO’s daily epidemiological update lists DRC 10,668 confirmed cases including 5,198 confirmed deaths (data as of 3 Nov; WHO). Different source and cut-off from the ECDC figures; not combined.Supplemental update for the November 3, 2026 edition: ECDC (3 Nov) reports DRC 10,532 confirmed cases including 5,126 related deaths (data through 1 Nov, reported as of 2 Nov).Supplemental update for the November 1, 2026 edition, checked October 31, 2026: ECDC (30 Oct) reports DRC 10,274 confirmed cases including 4,992 related deaths (as of 29 Oct, data to 28 Oct); Kenya unchanged at 9 cases including 2 deaths (as of 26 Oct).Record · Outbreak State
Australia: 8 of 12 AI scribes likely contain medical-device functions; the TGA did not test safety or privacy and did not say which eight. Record
EU: CHMP positive opinions, including oral orforglipron; Commission decision pending. Record
SOURCE-VERIFIED · EDITORIALLY REVISED · EDITION OF OCTOBER 19, 2026 · SUPERSEDED BY LATER EDITIONS
October 10, 2026 edition · Developments from September 25 to October 10
Latest record
Guidelines published · Source published · Event
WHO publishes separate obesity guidelines for children and adolescents
The two documents belong in one connected feature with two distinct source records.
WHO published two guidelines on October 7: one addresses children from 29 days to under 10 years, and the other addresses adolescents aged 10–19. The documents have separate publication records and age-specific scopes.
An integrated approach requires assessment, appropriate care and follow-up across the health system. A list of interventions discussed in a guideline is not permission to apply every intervention to every age. Families should receive guidance suited to age, development, associated conditions, preferences and the local clinical setting.
For clinicians, the next step is to read the applicable recommendation, its evidence assessment and implementation considerations before changing practice. For the website, the two sources can support a shared feature while retaining distinct citations. Neither should be relabeled as the other or merged out of the evidence register.
WHO sets a 2026–2035 roadmap for hypertensive disorders of pregnancy
The document coordinates research, implementation and accountability.
WHO’s new roadmap addresses hypertensive disorders of pregnancy through linked priorities in research, guidance, products, implementation and accountability. The publication page is dated October 7; the launch was covered October 8.
The roadmap is a global action framework. It does not replace a country’s clinical protocols or establish a new treatment threshold for an individual patient. Its practical value for health systems is to connect evidence, access, workforce readiness and measurement rather than treat publication of a guideline as proof that care has improved.
World Mental Health Day brings community care and lived experience into focus
WHO’s October material connects service reform with the supports people need outside institutions.
WHO’s October 9 community-care message and its October 10 World Mental Health Day campaign emphasize the role of people with lived experience in shaping mental-health services. Participation is more meaningful when it influences planning, governance and evaluation, rather than appearing only as a personal story.
Community care depends on accessible treatment, housing, social support, continuity and a workforce able to respond when needs change. A shift away from institutional models cannot be evaluated by closures alone. The relevant questions are whether people can obtain appropriate care, exercise their rights and sustain their lives in the community. These are system-design principles, not evidence that a particular California program has already achieved them.
Technical targets published · Source published · Event
WHO sets development targets for Taenia solium tests
Target product profiles describe what future diagnostics should achieve.
WHO published updated target product profiles on October 6 for tests addressing human taeniasis and human or pig cysticercosis. The profiles identify diagnostic gaps, intended uses and desired characteristics to guide research and development.
They include goals relevant to mapping transmission and identifying people who need referral in settings with limited imaging. These are targets for product development, not announcements of newly approved tests, and they do not substitute for clinical assessment of suspected neurocysticercosis.
Keep the report date and each underlying surveillance cutoff visible.
ECDC’s week 41 report, published October 9, cites 8,728 confirmed Ebola cases and 4,205 deaths in the Democratic Republic of the Congo using data through October 6, reported October 7. It also records Kenya’s reported imported case. These figures replace older current-layer totals; earlier totals should remain in dated historical entries.
The report also addresses pneumonia reports in Russia and notes that authorities had not confirmed plague. A suspected explanation should not become a confirmed diagnosis in a headline.
Different topics in a weekly report can use different observation periods. Publication on October 9 does not make every surveillance table current through that date, and a country-specific outbreak record does not establish a local California case or exposure.
Policy response and program launch · Source published · Event
UK accepts AI Commission recommendations and opens AI Airlock’s next phase
Lifecycle monitoring is the policy direction; implementation remains staged.
The UK government’s October 6 response accepts the AI Commission’s 44 recommendations and opens applications for AI Airlock Phase 3. The program focuses on monitoring and managing AI-enabled medical devices after deployment.
The announcement sets out future work, including draft guidance on managing changes and an implementation roadmap expected in spring 2027. Acceptance of recommendations is not the same as enacting every proposed requirement or approving a particular product. The useful comparison for California is how systems assess performance over time, inform patients and respond when a tool changes or fails—not whether one announcement proves a completed regulatory model.
Uk authorization announced · Source published · Event
UK authorizes catumaxomab for specified malignant ascites
The treatment aims to extend the interval before further drainage.
MHRA announced October 7 that catumaxomab, marketed as Korjuny, had been authorized October 2 for adults with malignant ascites when standard cancer treatment is no longer feasible. In the reported study of 258 patients with EpCAM-positive disease, the interval before further drainage was around 46 days with treatment after drainage, compared with 11 days with drainage alone.
The medicine requires specialist supervision and has significant adverse-effect considerations, including cytokine release syndrome. This is a UK authorization for a defined population. It should not be described as a cancer cure, an FDA approval or proof of routine US availability.
Recommendation published · Source published · Event
Australia publishes its 2027 influenza-vaccine composition recommendations
The committee met October 7; the statement was published October 9.
Australia’s influenza-vaccine committee issued recommendations for the 2027 southern-hemisphere season after reviewing circulating viruses and other evidence. The statement distinguishes egg-based from cell-based, recombinant and nucleic-acid vaccine components.
This is a formulation recommendation for Australia’s coming season. It does not replace US vaccination advice, establish local stock availability or prove the effectiveness of a product not yet used in that season. Travelers and clinicians should keep geography, season and vaccine platform attached to the recommendation.
Global · WHO bulletin published · surveillance data through
DR Congo reports 8,728 confirmed Bundibugyo Ebola cases as WHO confirms imported case in Kenya
The World Health Organization's October 8, 2026 Disease Outbreak News reports that, as of October 6, the Democratic Republic of the Congo had recorded 8,728 confirmed cases and 4,205 confirmed deaths in the Bundibugyo Ebola outbreak, a reported case-fatality ratio of 48.2%. The outbreak expanded to Alimbongo health zone in North Kivu. WHO also reported that an imported case with travel history from DR Congo was confirmed in Kenya, and that the affected patient died on October 5. WHO describes ongoing shortfalls in tracing and monitoring exposed contacts.
The October 8 publication does not provide an as-of-October-11 surveillance count. Confirmed cases are not all infections.
Earlier snapshot — WHO data through 23 September; ECDC data through 27 September
Global · Outbreak active
The Bundibugyo Ebola outbreak passes 8,000 confirmed cases
WHO reported 7,890 confirmed Bundibugyo Ebola cases and 3,799 deaths in the Democratic Republic of the Congo as of September 23, 2026. ECDC reported 8,116 cases and 3,924 deaths with data to September 27, across 63 of 167 health zones.